Funder
Harry Crossley Foundation
National Research Foundation
South African Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference31 articles.
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-tieulent J, Jemal A. Global Cancer statistics, 2012. CA Cancer J Clin [Internet]. 2015;65(2):87–108. Available from:
https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21262
.
2. Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol. 2005;205(2):275–92.
3. Barrett-Lee PJ, Dixon JM, Farrell C, Jones A, Leonard R, Murray N, et al. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Ann Oncol [Internet]. 2009;20(5):816–827. Available from:
https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdn728
.
4. Shi Y, Bieerkehazhi S, Ma H. Next-generation proteasome inhibitor oprozomib enhances sensitivity to doxorubicin in triple-negative breast cancer cells. Int J Clin Exp Pathol. 2018;11(5):2347–55.
5. Lee ER, Kim JY, Kang YJ, Ahn JY, Kim JH, Kim BW, et al. Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis. Biochim Biophys Acta - Mol Cell Res. 2006;1763(9):958–68.
Cited by
105 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献